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Summary
Study/principles: The effects of an outpatient pulmonary rehabilitation program on
psychological morbidity (anxiety and depressive symptoms) were examined in
patients with chronic obstructive pulmonary disease (COPD).
Methods: The 26 rehabilitation patients with COPD were compared with 19 control
patients with COPD similar in age, gender, COPD severity and other variables. Initial
assessment included lung function testing, health status, exercise tolerance,ee front matter & 2005
med.2005.09.031
ing author. Tel.: +90 232
ess: bkayahan@yahoo.cdyspnea intensity and psychiatric interviews using Hamilton depression rating scale
(HAM-D) and Hamilton anxiety rating scale (HAM-A). A pulmonary rehabilitation
program was carried out during the following 2 months; psychiatric interviews and
measurements of health status, exercise tolerance and dyspnea intensity were done
again on completion of the study at 2 months.
Results: There was a decrease in HAM-A scores in the rehabilitation group and the
decrease was statistically significant (P ¼ 0:010). On the contrary the HAM-A scores
did not change in control group. The decrease in HAM-A scores in rehabilitation
group was also statistically significant compared with the control group (P ¼ 0:042).
There was no significant difference in HAM-D scores within the two groups and also
there was no significant difference between the two groups in HAM-D scores. The
health status, exercise tolerance and dyspnea intensity improved significantly in the
rehabilitation group compared to the control group.
Conclusion: This study shows that our outpatient rehabilitation program leads to a
benefit in anxiety and depressive symptoms in COPD patients. The benefit was
especially significant in anxiety symptoms. In addition to the improvement inElsevier Ltd. All rights reserved.
3903401/mobile: +90 532 3020139; fax: +90 232 3398804.
om (B. Kayahan).
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were also significantly improved in COPD patients who underwent the rehabilitation
program. This outpatient-based rehabilitation program was well accepted by the
patients. The relatively simple design of the program makes it feasible indepen-
dently of expensive equipment.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) is
characterized by impaired respiratory airflow,
accompanied by an increasingly sedentary life-
style. A sedentary life-style, in turn, contributes
to reductions in functional capacity and physiologic
reserve, leaving the COPD patient with exertional
dyspnea, which often progresses into dyspnea at
rest. In addition to progressive physical disability,
past studies have found relatively high levels of
depression and anxiety among COPD patients.1
Depression and anxiety contribute more to func-
tional disability, poor health perception, and poor
well-being than many chronic medical condi-
tions.2,3 Patients with both chronic medical illness
and depression symptoms are functionally more
disabled than those with either a chronic medical
illness or depression alone. Furthermore, patients
with both conditions use greater resources, more
primary care services and more emergency care
than patients with chronic illness without depres-
sion.2,4,5 Recent studies also report a significant
relationship between the functional status of COPD
patients and the presence of anxiety or depres-
sion.2,6,7 Furthermore, several studies indicate that
pharmacotherapy of depression or anxiety in COPD
patients improves functional capacity.2,3,8,9
It has been suggested that changes in mood among
COPD patients may result from negative self-
perceptions and restrictions in behavioral function-
ing that are directly related to decreased physical
capacity. The clinical syndromes of depression and
anxiety may, in turn, further reinforce the COPD
patient’s social isolation and physical inactivity.1
Pulmonary rehabilitation programs aim at im-
proving dyspnea, exercise tolerance and the overall
quality of life. Several studies have shown benefits
of rehabilitation in patients with COPD.10–14 Some
studies have examined effects of pulmonary reha-
bilitation programs for anxiety and depression in
patients with COPD. After extensive multidisciplin-
ary rehabilitation, improved psychological symp-
toms have been observed. Levels of depression and
anxiety improved significantly in patients with
COPD after a 30-day exercise and rehabilitation
program.15 In a subsequent study, Emery et al.16found decreased anxiety among patients with COPD
participating in a comprehensive 10-week rehabi-
litation program (exercise, education and stress
reduction) compared with a group receiving educa-
tion and stress reduction alone. Similarly, Withers
et al. examined the effects of an outpatient
pulmonary rehabilitation program on anxiety in
patients with severe COPD. Their 6-week program
included exercise training, education, psychosocial
support and stress management. They too found
that the multifaceted pulmonary rehabilitation
program produced significant reductions in anxiety
symptom severity. One study examined exercise
alone. Participants who received 14 or 28 weeks of
aerobic activity experienced a significant decrease
in anxiety. Thus, it appears that multicomponent
rehabilitation programs that include exercise plus
psychoeducational components can produce mean-
ingful reductions in anxiety severity. These studies
demonstrated that exercise alone as well as a
combination of exercise, education and stress
management produce a decline in anxiety symp-
toms. According to cognitive-behavioral models of
anxiety, physical sensations and anxiety are
strongly linked. The exercise component may act
as a type of exposure therapy breaking the link
between physical sensations and anxiety.17
The purpose of the present study was to examine
the effects of an outpatient pulmonary rehabilita-
tion program on depressive and anxiety symptoms in
patients with COPD. Although exercise conditioning
has been found to improve the physical capacity of
COPD patients, few studies have examined the
effects of exercise on the psychological well-being
of COPD patients. It was hypothesized that subjects
completing the rehabilitation program experienced
improved psychological well-being.Patients and methods
Patients
The study included 52 patients who were treated in
the COPD outpatient unit of Department of
Pulmonology, School of Medicine, Ege University,
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according to the global initiative for chronic
obstructive lung disease (GOLD) criteria. Criteria
for inclusion in the study were: (1) age between 50
and 75 years; (2) history of smoking over 20 years
and no smoking for at least 1 year; and (3) to be in a
clinically stable condition (no exacerbations within
the last 8 weeks).
No changes were made in their drug therapy
during the study period. Patients with severe heart
disease, malignant disease, acute respiratory in-
fection, musculoskeletal disorders, peripheral vas-
cular disease or other disabling diseases and the
patients under long-term oxygen treatment were
excluded from the study. The patients were
randomised to two groups. The patients who met
inclusion criteria were dispersed one by one into
two groups. The patients were randomised after
they were referred to pulmonary rehabilitation by
their physicians. Twenty-six of the patients who
participated in the rehabilitation program were
enrolled in the study group and 26 of the patients
who did not to participate in the rehabilitation
program were enrolled in the control group. From
the control group seven patients did not appear for
their psychiatric interviews and other measure-
ments at the end of the study and the control group
was included only 19 patients. We suggested that
the patients who did not participate in the
rehabilitation program were not motivated to
complete all measurements. All of the patients
who participated in the rehabilitation program
completed the study. The study group included 21
men and 5 women. Their mean age was
64.8179.47 years and mean duration of illness
was 14.69711.36 years. The control group included
18 men and 1 woman. Their mean age was
67.2176.72 years and mean duration of illness
was 10.4777.09 years.Measures
Physiologic assessment
We assessed COPD severity with the lung function
testing with bronchodilator response, forced vital
capacity (FVC) and forced expiratory volume in 1 s
(FEV1) with the SensorMedikcs 2400 spirometer in
sitting situation.
Patients scored their dyspnea intensity on ver-
tical visual analogue scale (VVAS)18 and their
exercise tolerance was measured with the 6-min
walk test (SMWT).19,20
Patients’ health status was assessed with the St.
George’s Respiratory Questionnaire (SGRQ).21 It is a
self-complete questionnaire for measuring healthin chronic airflow limitation and the respiratory
symptoms, activity and impacts (on daily life) are
measured.Psychologic assessment
Anxiety and depressive symptoms in patients were
assessed using the Hamilton depression rating scale
(HAM-D)22 and Hamilton anxiety rating scale (HAM-
A)23 by a psychiatrist, who was trained and
experienced in using these scales. The psychiatrist
was blinded to the randomization group of the
patients.
The HAM-D is a 17-item scale that evaluates
depressed mood, vegetative and cognitive symp-
toms of depression, and comorbid anxiety symp-
toms. It provides ratings on current DSM-IV
symptoms of depression, with the exceptions of
hypersomnia, increased appetite and concentra-
tion/indecision. The HAM-D was originally designed
to be administered by a trained clinician using a
semi-structured clinical interview. The administra-
tor must be experienced in clinical psychopathol-
ogy. The HAM-D measures the change in severity of
depressive symptoms. It is not used for the
diagnosis of depression.
However, Hamilton provided only general guide-
lines for the administration and scoring of the
scale. No standardized probe questions were
provided to elicit information from patients and
no behaviorally specific guidelines were developed
for determining each item’s rating. The 17 items
are rated on either a five-point (0–4) or a three-
point (0–2) scale. In general, the five-point scale
items use a rating of 0 ¼ absent, 1 ¼ doubtful to
mild, 2 ¼ mild to moderate, 3 ¼ moderate to
severe and 4 ¼ very severe. A rating of 4 is usually
reserved for extreme symptoms. The three-point
scale items use a rating of 0 ¼ absent,
1 ¼ probable or mild and 2 ¼ definite. Score level
of depression is 0–7; no depression, 8–12; mild
depression, 13–17; mild to moderate depression,
417: moderate to severe depression. The highest
score of the scale is 53.
The HAM-D was one of the first rating scales
developed to quantify the severity of depressive
symptomatology. First introduced by Max Hamilton
in 1960, it has since become the most widely used
and accepted outcome measure for evaluating
depression severity.
The psychometric properties of the original
clinician-administered scale has been well
documented. It has been found more sensitive
as a treatment change measure (both drug
and psychotherapy) than several self-rated
scales.
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each defined by a series of symptoms. As was the
case with the HAM-D, Hamilton provided only
general guidelines regarding the administration
and scoring of the scale. No standardized probe
questions to elicit information from patients, or
behaviorally specific guidelines were developed for
determining item scoring. The administrator must
be experienced in clinical psychopathology. Similar
to the HAM-D, each item is rated on a five-point
scale, ranging from 0 (not present) to 4 (severe).
The highest score of the scale is 56.
The HAM-A was one of the first rating scales
developed to quantify the severity of anxiety
symptomatology. Since its introduction by Max
Hamilton in 1959, it has become a widely used
and accepted outcome measure for the evaluation
of anxiety in clinical trials.
Study design
An initial assessment was performed in all patients.
During the following 2 months the rehabilitation
program was carried out. The other assessments
were performed at the end of second month.
Rehabilitation program
The patients in the study group in addition to their
medical treatment underwent an outpatient pul-
monary rehabilitation program for 2 months, 3 days
and 2 12 h weekly. The rehabilitation program in-
cluded:1. Education: This consisted of group sessions and
private counseling on the anatomy and physio-
logical basis of COPD, medicinal information,
nutrition, adaptation to COPD and advice on how
to manage with COPD in everyday life (one
session of, half an hour, weekly).2. Relaxation exercise: Relaxation exercises iden-
tified by Jacobson were applied to patients.3. Bronchial hygiene program: The purpose of this
part of the program was to teach the patients
the most effective way of coughing to clean
their lungs. The patients were also taught how
to remove secretions from their lungs using
simple postures.4. Breathing retraining: The aim of this stage was
to teach the patients how to breathe in the most
effective way in different situations. The most
important components of retraining were:
pursed lip breathing, diaphragmatic breathing,
segmental breathing and walking with a forward
leaning posture. The importance of using thesebreathing techniques especially during exercise
and other physical activities was emphasized.5. Upper body muscle strengthening exercises,
postural exercises and chest mobilizing exer-
cises.6. Warm-up gymnastics, high intensity upper and
lower extremity training—e.g. 15min of rapid
walking and 15min of arm ergometry—cool-up
gymnastics.7. Cardiopulmonary exercise: 15min riding on a
stationary bicycle.
Statistical analysis
Statistical analyses were performed with a
Statistical Package for Social Sciences for Windows
10.0. Comparisons of patients’ parameters in
groups were done using paired-samples t-test and
comparisons of patients’ parameters between
groups were done using independent-samples
t-test. Non-parametric tests, Wilcoxon signed
ranks test and Mann–Whitney U-test, were used
when parametric tests were inappropriate. Com-
parison of scores of HAM-D and HAM-A scales
between groups was done using Repeated Measures
Test. w2-test was used to compare mean values
between groups. Results were expressed as
mean7standard deviation (SD). The significance
level was set at Po0:05.Results
Fifty-two patients were included in the study but
only 45 patients completed the study. Twenty-six
patients were in rehabilitation group and 19
patients were in the control group. The rehabilita-
tion program was well tolerated and accepted
among patients; there were no adverse events.
Patients’ socio-demographic characteristics and
baseline parameters (smoking, oxygen use, comor-
bidity, X-ray finding, drug treatments, severity of
disease, FVC, FEV1) are shown in Table 1.
According to GOLD criteria one patient was
Grade I (3.8%), 15 patients were Grade II (57.7%)
and 10 patients were Grade III (38.5%) in rehabilita-
tion group and one patient was Grade I (5.3%), 11
patients were Grade II (57.9%) and seven patients
were Grade III (36.8%) in control group. There was
no statistically significant difference between the
rehabilitation and control groups due to severity of
COPD (P40:05).
There was a decrease in HAM-A scores in the
rehabilitation group and the decrease was statisti-
cally significant (P ¼ 0:010). On the contrary
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Table 1 Comparison of socio-demographic characteristics and baseline parameters of patients in rehabilitation
and control groups (P40:05).
Rehabilitation group (n ¼ 26) Control group (n ¼ 19)
Age (years) 64.8179.47 (47–76) 67.2176.72 (54–79)
Sex (M/F) 21/5 (80.8–19.2%) 18/1 (94.7–5.3%)
Smoking (boxes/year) 48.08731.84 (0–150) 43.21727.92 (0–120)
Duration of illness 14.69711.36 (2–50) 10.4777.09 (1–20)
Oxygen use (7) 2/24 (7.7–92.3%) 1/18 (5.3–94.7%)
Comorbidity (7) 10/16 (38.5–61.5%) 11/8 (57.9/42.1%)
X-ray finding (7) 16/10 (61.5–38.5%) 13/6 (68.4–31.6%)
Corticosteroid use (7) None None
Theophylline use (7) 12/14 (46.2–53.8%) 9/10 (47.4–52.6%)
Beta agonist use (7) 15/11 (57.7–43.3%) 13/6 (68.4–31.6%)
FVC (ml) 2300 2360
FEV1 (ml) 1470 (55.50%) 1390 (58%)
All P-values are 40.05 and there is no significant difference between rehabilitation and control groups in socio-demographic
characteristics and other baseline parameters.
Table 2 Comparison of mean HAM-A scores of the rehabilitation and control groups at baseline and at the end of
rehabilitation program.
HAM-A1 HAM-A2 t Mean difference P
Rehabilitation group (n ¼ 26) 8.9176.94 5.8773.84 2.831 3.04* 0.010
Control group (n ¼ 19) 7.9176.64 8.7377.63 0.601 0.82 0.561
P: 0.010 (Po0:05).
*Statistically significant.
Table 3 Comparison of mean HAM-D scores of the rehabilitation and control groups at baseline and at the end of
rehabilitation program.
HAM-D1 HAM-D2 t Mean difference P
Rehabilitation group (n ¼ 26) 5.4374.84 4.0072.94 1.564 1.43 0.132
Control group (n ¼ 19) 7.1876.49 5.5573.96 1.381 1.64 0.197
Table 4 Comparison of changes in HAM-A and
HAM-D scores between groups at the end of the
study.
F P
HAM-AGROUPS 4.503 0.042*
HAM-DGROUPS 0.017 0.898
*Statistically significant (Po0:05).
B. Kayahan et al.1054the HAM-A scores did not change in control group
(Table 2).
There was no significant change in HAM-D scores
in the rehabilitation and control groups (Table 3).
At the end of the study there was statistically no
difference in HAM-D scores between two groups.
But there was a statistically significant decrease
in HAM-A scores in the rehabilitation group
when compared to the control group (P ¼ 0:042)
(Table 4).
The health status, quality of daily life (SGRQ),
dyspnea intensity (VVAS) and exercise toler-
ance (SMWT) improved significantly in the rehabi-
litation group compared to the control group
(Tables 5–7).Discussion
Our study found significant improvement in anxiety
symptoms in COPD patients in the rehabilitation
ARTICLE IN PRESS
Table 5 Comparison of mean VVAS scores of the rehabilitation and control groups at baseline and at the end of
rehabilitation program.
VVAS1 VVAS2 P
Rehabilitation group (n ¼ 26) 5.9672.03 3.0871.64 o0.05*
Control group (n ¼ 19) 5.2972.08 5.8871.83
VVAS, vertical visual analogue scale.
*Statistically significant (Po0:05).
Table 6 Comparison of mean SMWTscores of the rehabilitation and control groups at baseline and at the end of
rehabilitation program.
SMWT1 (m) SMWT2 (m) P
Rehabilitation group (n ¼ 26) 261.677141.5 383.21799.4 o0.05*
Control group (n ¼ 19) 226.827172.7 241.947187.46
SMWT, 6-min walk test.
*Statistically significant (Po0:05).
Table 7 Comparison of mean SGRQ scores of the rehabilitation and control groups at baseline and at the end of
rehabilitation program.
SMWT1 SMWT2 P
Rehabilitation group (n ¼ 26) 45.08717.78 28.29715.16 o0.05*
Control group (n ¼ 19) 50.65715.23 47.00717.38
SGRQ, St. George’s Respiratory Questionnaire.
*Statistically significant (Po0:05).
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proposed that anxiety is closely associated with
dyspnea in COPD patients and exercise training
alone or rehabilitation programs result in decreases
in dyspnea and dyspnea-related anxiety.24 In the
present study, dyspnea intensity (VVAS) also im-
proved significantly in the rehabilitation group
compared to control group. There was no signifi-
cant improvement in depressive symptoms in both
groups. We suggest that improvement in depressive
symptoms (especially the core symptoms of depres-
sion like depressive mood and anhedonia) with
pulmonary rehabilitation programs is much more
difficult.
The health status, quality of life (SGRQ) and
exercise tolerance (SMWT) also improved signifi-
cantly in the rehabilitation group compared to the
control group in our study. Our results are in line
with the previous studies. Pulmonary rehabilitation
programs aim at improving dyspnea, exercise
tolerance and the overall quality of life. Several
studies have shown benefits of rehabilitation in
patients with COPD.25–28These data suggest the efficacy of pulmonary
rehabilitation in psychological well-being among
patients with COPD. Psychological measures indi-
cate that subjects experienced improved well-
being, including reductions in anxiety and depres-
sion, following the rehabilitation program. Our
results support previous studies29–35 and indicate
that psychological improvement follows rehabilita-
tion in patients with COPD.
Our study has some advantages. First, the way in
which anxiety and depressive symptoms are mea-
sured is very important in such studies. The
researchers need to use assessment instruments
that have demonstrated reliability and validity. The
present study includes a more extensive assessment
of psychological well-being. A psychiatrist who is
experienced in using HAM-D and HAM-A scales
assessed the anxiety and depressive symptoms in
COPD patients. So the measurement of depressive
and anxiety symptoms is more reliable than
measurements in other numerous studies using
self-report scales for depressive and anxiety symp-
toms. Another advantage of our study is the
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an implication in the validity of our study.
Our study has some limitations too. Methodolo-
gical problems (e.g. the small number of partici-
pants in both groups) likely reduced the overall
generalizability of our findings.
Our study results provide no indication of
possible mechanisms responsible for change in
psychological well-being. Improvement on psycho-
logical measures may be a reflection of motiva-
tional factors and social support provided by
regular meetings in a group setting.
The program was suggested to be psychother-
apeutic for a patient in at least the following ways:
(a) by providing long-term emotional support to the
patient through continuing social interaction with
the staff; (b) by encouraging the patient to
experience mastery over his chronic disease, and
optimism about controlling it, through education
and through the learning of specific medical
techniques for dealing with it (e.g. systematic
bronchial hygiene and breathing retraining); and
(c) on the assumption that these techniques are
effective, by enhancing the patients’ feeling of
emotional well-being as a response to his improved
physical well-being.36
Despite the methodological problems, these
findings indicate that patients with COPD are likely
to have important psychological improvement after
a pulmonary rehabilitation program.
The previous studies37–39 show that pulmonary
rehabilitation produces obvious short-term effects
on psychological variables, but the effects usually
diminish over longer follow-ups. It is obvious that
for continuous effects on the psychological well-
being, the patients require continuous rehabilita-
tive work. We suggest that simple design of the
outpatient-based rehabilitation program used in
our study can provide the patients this continuous
rehabilitative work.
In summary, we examined the effects of an
outpatient-based pulmonary rehabilitation pro-
gram on anxiety and depressive symptoms in
patients with COPD. The program was carried out
during 2 months. We found significant decrease in
the anxiety symptoms in the rehabilitation group at
the end of the program and also this decrease was
statistically significant compared to the control
group. There was no significant improvement in
depressive symptoms in both groups.
As a result this study was planned to examine the
feasibility and acceptance of this kind of ‘‘mod-
ular’’ pulmonary rehabilitation program. Our study
demonstrated that this outpatient-based rehabili-
tation program is effective and well accepted
among patients. The relatively simple design ofthe program makes it feasible independently of
expensive equipment.References
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